apatinib and Sarcoma--Ewing

apatinib has been researched along with Sarcoma--Ewing* in 1 studies

Other Studies

1 other study(ies) available for apatinib and Sarcoma--Ewing

Article	Year
Renal Ewing sarcoma treated with apatinib. Anti-cancer drugs, 2018, Volume: 29, Issue:7 Renal Ewing sarcoma (RES) is an extremely rare disease. The standard treatment for this disease is lacking, and clinical experience needs to be accumulated. Here, we report a case of RES that rapidly developed to metastatic disease and was refractory to radiotherapy and chemotherapy; however, the case obtained a partial response based on Choi criteria by orally taking antiangiogenic drug apatinib. Our case suggests that apatinib may be a therapeutic option for RES. Topics: Adult; Antineoplastic Agents; Humans; Kidney Neoplasms; Male; Progression-Free Survival; Pyridines; Sarcoma, Ewing	2018

Article

Year

Renal Ewing sarcoma treated with apatinib.

Anti-cancer drugs, 2018, Volume: 29, Issue:7

Renal Ewing sarcoma (RES) is an extremely rare disease. The standard treatment for this disease is lacking, and clinical experience needs to be accumulated. Here, we report a case of RES that rapidly developed to metastatic disease and was refractory to radiotherapy and chemotherapy; however, the case obtained a partial response based on Choi criteria by orally taking antiangiogenic drug apatinib. Our case suggests that apatinib may be a therapeutic option for RES.

Topics: Adult; Antineoplastic Agents; Humans; Kidney Neoplasms; Male; Progression-Free Survival; Pyridines; Sarcoma, Ewing

2018